iOmx Therapeutics Initiates Phase Ib with OMX-0407
22 Aug 2024 //
GLOBENEWSWIRE
iOmx to Present New Data on Lead Programs & I/O Platform at AACR 2024
03 Apr 2024 //
GLOBENEWSWIRE
iOmx Therapeutics to Present Target Discovery Platform Myeloid iOTarg
15 Mar 2023 //
GLOBENEWSWIRE
iOmx to Present New PC Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 2022
06 Apr 2022 //
GLOBENEWSWIRE